EVIDENT Corporation Appoints New CEO and COO

16-Aug-2023 - Japan

Evident Corporation announced the appointment of William Wesley “Wes” Pringle as Chief Executive Officer (CEO) and Hiroyuki Yoshimoto as President and Chief Operating Officer (COO). Effective immediately, Wes takes over for Evident’s interim CEO Eric Anderson.

William Wesley “Wes” Pringle

Hiroyuki Yoshimoto

Wes has an impressive 30-year career driving growth and business transformation across a variety of industries, including consumer, industrial, healthcare and software-enabled businesses. Prior to joining Evident, Wes ran several companies for Danaher including Fluke Corporation (a global test and measurement leader), which he led for almost 10 years.  As President of Fluke, Wes oversaw a period of significant growth and market expansion.  More recently, he served as Head of Portfolio Operations at the private equity firm Onex Corporation, where he helped over a dozen portfolio companies accelerate performance.

Hiroyuki is an experienced leader with a proven track record of leading global companies headquartered in Japan and the USA.  Prior to joining Evident, Hiroyuki had several senior leadership roles at global manufacturing companies such as Nissan Motor Corporation Group and Nidec Corporation. He led significant business growth by expanding market share and providing  hands-on leadership for operational excellence. Most recently, he served as Senior Vice President and Japan Representative at American Express, where he led the business on a remarkable growth journey.

Other news from the department business & finance

Most read news

More news from our other portals

So close that even
molecules turn red...

Last viewed contents

Danaher appoints Christopher Riley to Executive Vice President for Biotechnology

Danaher appoints Christopher Riley to Executive Vice President for Biotechnology

Biotage AB appointment of new CEO

Biotage AB appointment of new CEO

Dr. Christine Munz becomes CEO at Eppendorf - Dr. Wilhelm Plüster completes term in office as planned

Dr. Christine Munz becomes CEO at Eppendorf - Dr. Wilhelm Plüster completes term in office as planned

Jung Foundation honours cutting-edge research: 4 prizes for medical breakthroughs - Their research has the potential to decisively transform the medicine of tomorrow, or has already done so

Jung Foundation honours cutting-edge research: 4 prizes for medical breakthroughs - Their research has the potential to decisively transform the medicine of tomorrow, or has already done so

Leadership change at Köttermann B.V. in the Netherlands

Leadership change at Köttermann B.V. in the Netherlands

1.2 million US dollar award honors pioneering work in cryo-electron tomography - Wolfgang Baumeister receives prestigious Shaw Prize

1.2 million US dollar award honors pioneering work in cryo-electron tomography - Wolfgang Baumeister receives prestigious Shaw Prize

Leon-nanodrugs appoints Dr. Wolfgang Hofmann as Chief Executive Officer

Leon-nanodrugs appoints Dr. Wolfgang Hofmann as Chief Executive Officer

Refeyn Announces Leadership Transition - Jonathan Flint Steps Down as Chairman, Jean-Paul Mangeolle Appointed as Successor

Refeyn Announces Leadership Transition - Jonathan Flint Steps Down as Chairman, Jean-Paul Mangeolle Appointed as Successor

Joachim Kreuzburg, Former CEO of Sartorius, Joins Cube Biotech’s Board of Directors

Joachim Kreuzburg, Former CEO of Sartorius, Joins Cube Biotech’s Board of Directors

New high-tech startup developing smart contact lenses for glaucoma diagnosis and management

New high-tech startup developing smart contact lenses for glaucoma diagnosis and management

Insilico Medicine brings AI-powered “ChatPandaGPT” to its target discovery platform - A revolution in drug discovery thanks to a new chat assistant?

Insilico Medicine brings AI-powered “ChatPandaGPT” to its target discovery platform - A revolution in drug discovery thanks to a new chat assistant?

Insilico Medicine-led study combines quantum computing and generative AI for drug discovery - “Quantum computing is recognized as the next technology breakthrough which will make a great impact, and the pharmaceutical industry is believed to be among the first wave of industries benefiting from the advancement”

Insilico Medicine-led study combines quantum computing and generative AI for drug discovery - “Quantum computing is recognized as the next technology breakthrough which will make a great impact, and the pharmaceutical industry is believed to be among the first wave of industries benefiting from the advancement”